Imbrium Therapeutics LP

Alcohol Use Disorder

Clinical research activity is focused on alcohol use disorder, with interest in reducing heavy drinking and improving outcomes related to alcohol consumption.

  • Alcohol dependence
  • Heavy drinking days
  • Alcohol consumption reduction

The sponsor’s trial portfolio centers on therapeutic approaches for substance use disorder within the field of addiction medicine.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Sunobinop on Reducing Alcohol Consumption in Patients with Moderate to Severe Alcohol Use Disorder Seeking Treatment

    Not recruiting

    2 1
    Investigated diseases:
    Romania